Showing results (211-220 of 324) with videos related to
Sort By:
Pageof 33
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Phase II study of liposomal muramyl tripeptide phosphatidylethanolamine (MTP/PE) in advanced soft tissue sarcomas of the adult. An EORTC Soft Tissue and Bone Sarcoma Group studyJ Verweij, I Judson, W Steward, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1997
Phase II trial of the oral platinum complex JM216 in non-small-cell lung cancer: an EORTC early clinical studies group investigationI Judson, T Cerny, R Epelbaum, et al.British Journal of Cancer|November 27, 1999
Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignanciesM Brada, I Judson, P Beale, et al.British Journal of Cancer|October 1, 1994
A Cancer Research Campaign (CRC) phase II trial of CB10-277 given by 24 hour infusion for malignant melanomaN M Bleehen, A H Calvert, S M Lee, et al.British Journal of Cancer|April 1, 1995
Continuous-infusion verapamil with etoposide in relapsed or resistant paediatric cancersF J Cowie, C R Pinkerton, M Phillips, et al.British Journal of Cancer|October 21, 2004
Phase I/II study of DHA-paclitaxel in combination with carboplatin in patients with advanced malignant solid tumoursM Harries, A O'Donnell, M Scurr, et al.British Journal of Cancer|September 1, 2012
Safety, tolerability, pharmacokinetics and pharmacodynamics of AZD8055 in advanced solid tumours and lymphomaA Naing, C Aghajanian, E Raymond, et al.Journal of Chromatography. B, Biomedical Applications|October 6, 1995
Development and validation of a solid-phase extraction and high-performance liquid chromatographic assay for a novel fluorinated 2-nitroimidazole hypoxia probe (SR-4554) in Balb/c mouse plasmaE O Aboagye, M A Graham, A D Lewis, et al.Molecular Pharmacology|October 20, 2000
Establishment of an isogenic human colon tumor model for NQO1 gene expression: application to investigate the role of DT-diaphorase in bioreductive drug activation in vitro and in vivoS Y Sharp, L R Kelland, M R Valenti, et al.European Journal of Cancer Care|April 30, 2015
Cost of treatment in patients with metastatic soft tissue sarcoma who respond favourably to chemotherpy. The SArcoma treatment and Burden of Illness in North America and Europe (SABINE) studyL Jönsson, N Justo, A Musayev, et al.Pageof 33